Entering text into the input field will update the search result below

P3 Health Partners: Right Place, Right Time, Wrong Horse To Back?

Sep. 10, 2023 8:31 AM ETP3 Health Partners Inc. (PIII)

Summary

  • P3 Healthcare, operating in the value-based care space, has seen its stock price plummet by ~80% since its Nasdaq listing.
  • The company operates within the Medicare Advantage market and provides comprehensive healthcare services to MA plan members on behalf of healthcare payors.
  • P3's recent performance has shown some solid revenue growth and a decrease in net losses, but funding is running out and momentum is being checked in several key areas.
  • Since my June "Hold" recommendation, P3's stock price is down >50%, after a long bull run. Unfortunately, the challenges of uncertain yet crowded market mean things may get worse before they get better.

Horse Racing

kevinjeon00/E+ via Getty Images

Investment Overview

When I last wrote about P3 Health Partners (NASDAQ:PIII) for Seeking Alpha back in June, I advised readers that the company was operating in "an intriguing space" - value based care - with "narrowing losses", and that it

If you like what you have just read and want to receive at least 4 exclusive stock tips every week focused on Pharma, Biotech and Healthcare, then join me at my marketplace channel, Haggerston BioHealth. Invest alongside the model portfolio or simply access the investment bank-grade financial models and research. I hope to see you there.

This article was written by

Edmund Ingham profile picture
9.81K Followers

I write about Biotech, Pharma and Healthcare stocks and share investment tips. Find me at my marketplace channel, Haggerston BioHealth - model portfolio + 4 exclusive stock tips every week. I'm on twitter @edmundingham

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

Comments

Disagree with this article? Submit your own. To report a factual error in this article, . Your feedback matters to us!
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.